Request Demo
Last update 09 Sep 2025
ALK x DNA
Last update 09 Sep 2025
Related
NCT06528691
PHASE 2 Study of Entrectinib as a Single Agent in Upfront Therapy for Children <3 Years of Age With NTRK1/2/3 or ROS1-FUSED CNS Tumors (GLOBOTRK)
NCT06692491
A Phase II Clinical Study on Precision Treatment of Rare Tumours in China Guided by Patient-Derived Tumor Organoids (PDO) and Next-Generation Sequencing (NGS)
CTR20243865
一项在根据生物标志物状态选择的可切除I-III期非小细胞肺癌患者队列中评价多种治疗有效性和安全性的多中心I-III期研究
[Translation] A multicenter phase I-III study evaluating the efficacy and safety of multiple treatments in a cohort of patients with resectable stage I-III non-small cell lung cancer selected by biomarker status
100 Clinical Results associated with ALK x DNA
Login to view more data
100 Translational Medicine associated with ALK x DNA
Login to view more data
Login to view more data
Analysis
Perform a panoramic analysis of this field.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free